The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma.
 
Sara Kuruvilla
Honoraria - AstraZeneca Canada; Bristol-Myers Squibb; Merck; Sanofi
Consulting or Advisory Role - AstraZeneca Canada; Bristol-Myers Squibb; Sanofi
Research Funding - AstraZeneca Canada
 
Brandon M. Meyers
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Purdue Pharma; Roche Canada
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis/Ipsen (Inst); Galera Therapeutics (Inst); GlaxoSmithKline Canada (Inst); H3 Biomedicine (Inst); Sillajen (Inst)
Expert Testimony - Eisai; Roche Canada
Travel, Accommodations, Expenses - Eisai; Merck Serono
 
Christina Parker
No Relationships to Disclose
 
Anthony C. Nichols
Employment - Need
Stock and Other Ownership Interests - Need
Research Funding - Novartis Canada Pharmaceuticals Inc (Inst); Sequenom
Patents, Royalties, Other Intellectual Property - Patent for UWO3 prognostic score for HPV-positive oropharyngeal cancer
 
Martin Smoragiewicz
No Relationships to Disclose
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Bayer; Eisai; Ipsen; Janssen Oncology; Merck
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SignalChem (Inst)
Travel, Accommodations, Expenses - Eisai
 
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Honoraria - AstraZeneca; AstraZeneca
Consulting or Advisory Role - Merck; Profound Medical; Takeda
 
Alexander V. Louie
Honoraria - AstraZeneca Canada
Speakers' Bureau - AstraZeneca Canada
 
Paul Stewart
No Relationships to Disclose
 
Morgan Black
No Relationships to Disclose
 
Caitlin Carreau
No Relationships to Disclose
 
Justin Lee
No Relationships to Disclose
 
Nancy Read
No Relationships to Disclose
 
Jinka Sathya
No Relationships to Disclose
 
Pencilla Lang
No Relationships to Disclose
 
Fung Kevin
No Relationships to Disclose
 
Varagur Venkatesan
No Relationships to Disclose
 
Richard B. Kim
No Relationships to Disclose
 
David A. Palma
Employment - London Health Sciences Centre (LHSC)
Patents, Royalties, Other Intellectual Property - US Patent: A Method for Analyzing a Three-Dimensional Computed Tomography Image, United States Patent Application No. 61/896349 (not licensed, no commercial or financial impact)
 
Eric Winquist
Consulting or Advisory Role - Amgen; Bayer; Eisai; Ipsen; Merck; Roche
Research Funding - Ayala Pharmaceuticals (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)